Holding Hope: Israel’s Weekly Protests Demand Hostage Return
Weekly protests in Israel demand ceasefire and the return of hostages taken by Hamas in October 2023. Over 100 remain unaccounted for.
‘Caught in a Year of Darkness’ Documentary Sheds Light on Palestinian-Israeli Conflict
‘Caught in a Year of Darkness’ documentary highlights the human stories behind the Palestinian-Israeli conflict, urging a call for peace.
New Docu Exposes Human Toll of Palestinian-Israeli Conflict 🌍💔
CGTN’s new documentary ‘Caught in a Year of Darkness’ exposes the escalating Palestinian-Israeli conflict through personal stories of loss, resilience, and hope. 🌍🕊️
Middle East Conflict: One Year Later 🕊️⚡
One year since the Middle East conflict reignited. Protests surge as Beirut faces strikes. CGTN correspondents deliver real-time insights from the frontlines.
China’s Holiday Travel Rush Peaks: Millions Hit the Road 🚄
As China’s National Day holiday ends, millions embark on return journeys. Dive into the travel rush dynamics and cultural insights. 🚆 #ChinaTravel
Wooden Wonders: A Craftsman’s 38-Year Legacy 🪵✨
Pan Haiyuan’s 38-year journey preserving Xiamen’s wooden molds faces challenges from machines and fading apprentice interest. 🌏🪓 #CulturalHeritage
Elon Musk Joins Donald Trump at PA Rally, Calls Election a ‘Must-Win’
Elon Musk joins Donald Trump at a Pennsylvania rally, calling the upcoming election a ‘must-win’ and urging supporters to register to vote. 🚀🇺🇸
Elon Musk Joins Trump at PA Rally: ‘Must-Win’ Election Bid 🗳️🇺🇸
Elon Musk endorses Trump at a Pennsylvania rally, calling the election a ‘must-win’ and urging voter turnout. Security updates follow recent assassination attempts.
Global Protests Erupt Against Middle East Conflict 🌍✊
Thousands worldwide rally against the Middle East conflict, demanding peace and an end to military actions in Gaza and Lebanon. 🌍✌️ #GlobalProtests
First Donor Cell Therapy Puts Autoimmune Disorders into Remission
Three patients from the Chinese mainland have entered remission from severe autoimmune diseases using a pioneering donor-derived CAR-T cell therapy, marking a significant medical breakthrough.